- Home
- APLT vs MPTI Comparison
APLT vs MPTI Comparison
Compare APLT & MPTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLT
- MPTI
- Stock Information
- Founded
- APLT 2016
- MPTI 1965
- Country
- APLT United States
- MPTI United States
- Employees
- APLT N/A
- MPTI N/A
- Industry
- APLT Biotechnology: Pharmaceutical Preparations
- MPTI
- Sector
- APLT Health Care
- MPTI
- Exchange
- APLT Nasdaq
- MPTI Nasdaq
- Market Cap
- APLT 178.6M
- MPTI 158.5M
- IPO Year
- APLT 2019
- MPTI N/A
- Fundamental
- Price
- APLT $1.30
- MPTI $54.00
- Analyst Decision
- APLT Buy
- MPTI
- Analyst Count
- APLT 5
- MPTI 0
- Target Price
- APLT $4.13
- MPTI N/A
- AVG Volume (30 Days)
- APLT 5.5M
- MPTI 24.1K
- Earning Date
- APLT 11-10-2025
- MPTI 11-12-2025
- Dividend Yield
- APLT N/A
- MPTI N/A
- EPS Growth
- APLT N/A
- MPTI 45.88
- EPS
- APLT N/A
- MPTI 2.57
- Revenue
- APLT $121,000.00
- MPTI $52,033,000.00
- Revenue This Year
- APLT N/A
- MPTI $12.06
- Revenue Next Year
- APLT $5,935.35
- MPTI $11.80
- P/E Ratio
- APLT N/A
- MPTI $20.99
- Revenue Growth
- APLT N/A
- MPTI 16.52
- 52 Week Low
- APLT $0.30
- MPTI $28.75
- 52 Week High
- APLT $10.62
- MPTI $60.00
- Technical
- Relative Strength Index (RSI)
- APLT 62.38
- MPTI 53.92
- Support Level
- APLT $1.16
- MPTI $51.03
- Resistance Level
- APLT $1.50
- MPTI $55.61
- Average True Range (ATR)
- APLT 0.15
- MPTI 2.15
- MACD
- APLT -0.01
- MPTI -0.45
- Stochastic Oscillator
- APLT 66.64
- MPTI 45.91
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.
About MPTI M-tron Industries Inc.
M-Tron Industries Inc is a diversified holding company with subsidiaries engaged in designing, manufacturing, and marketing high-engineered, high-reliability frequency and spectrum control products used to control the frequency or timing of signals in electronic circuits in various applications. The company's serving markets are aerospace and defense, space, and avionics. The company offers products such as microwave and millimeter wave filters; cavity, crystal, ceramic, lumped element, and switched filters; crystal resonators, integrated microwave assemblies, and solid-state power amplifier products.